<?xml version='1.0' encoding='utf-8'?>
<document id="23334563"><sentence text="Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic." /><sentence text="Drug interactions are important potential causes of adverse drug reactions" /><sentence text=" However, studies of their occurrence in children are almost entirely lacking" /><sentence text=" This study evaluates the incidence of potential drug interactions (PDIs) in medication prescriptions for children" /><sentence text=" The study was performed at the University Hospital in Olomouc" /><sentence text=" PDIs in each patient's prescriptions were identified" /><sentence text=" Multivariate analysis was performed in order to assess the risk factors confounding the potential interactions" /><sentence text=" Univariate analysis was used to assess which diagnostic groups and medication groups significantly increase or lower the odds of a potential drug-drug interaction" /><sentence text=" A total of 6,078 patients meeting the inclusion criteria entered the study" /><sentence text=" They received 19,522 prescriptions" /><sentence text=" PDIs were identified in 3" /><sentence text="83 % of patients (moderate-to-severe cases in 0" /><sentence text="47 %)" /><sentence text=" Patient age (p = 0" /><sentence text="008), the average number of prescriptions per visit (p &lt; 0" /><sentence text="0001), and the number of visits per year (p &lt; 0" /><sentence text="0001) were found to increase the risk of drug interaction" /><sentence text=" The presence of epilepsy, leukemia, or rheumatoid arthritis and related disease diagnoses were discovered to increase the risk of PDIs significantly" /><sentence text="" /><sentence text="The risk of PDIs in children is low, but it increases significantly with age and the number of drugs prescribed, particularly antiepileptics and immunosuppressants" /><sentence text=" The finding of a potential interaction in 0" /><sentence text="47 % of all children in whom any medication was prescribed should not be underestimated since it means a significant risk for one child out of every 200, and it is also substantially higher in the chronically ill" /><sentence text=" Pediatricians should be aware of relevant interactions and should prevent them by therapeutic drug monitoring or appropriate clinical and laboratory monitoring" /><sentence text="" /></document>